Family Medicine Doctors in Arcadia, CA Accepting Medicare

23 Family Medicine doctors found. Showing 21 - 23

Monique B. Williams, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 159 E Live Oak Ave, Suite 108, Arcadia, CA 91006 Phone: 626-574-3038

Joseph R Tafur, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 650 W. Duarte, Suite 100 A, Arcadia, CA 91007 Phone: 626-821-9631    Fax: 626-821-9631

Dr. Shye-ren Yeh, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 638 W Duarte Rd, Suite 8, Arcadia, CA 91007 Phone: 626-574-1189    Fax: 626-574-7812

News Archive

Odyssey Thera receives US patent for application of contextual high-content assays to diverse biological events

Odyssey Thera, Inc. announced today that the United States Patent and Trademark Office granted U.S. Patent No. 7,935,493, entitled "Protein fragment complementation assays for high-throughput and high-content screening."

IFCC enhances quality of diagnosis and therapy to improve clinical outcomes for patients worldwide

The International Federation of Clinical Chemistry and Laboratory Medicine is an organization of 90 Full Members National Societies, 12 Affiliate Members National Societies and 46 Corporate Members serving laboratory professionals worldwide and representing 45,000 laboratory medicine specialists world-wide.

First step in developing evidence-based concussion guidelines

A research review identifying the clinical indicators most strongly associated with concussion is an important first step in the process of developing evidence-based guidelines for concussion diagnosis, prognosis, and treatment, according to a new report published by Neurosurgery, official journal of the Congress of Neurological Surgeons.

Favorite music has greatest impact on brain connectivity

It doesn't matter if it's Bach, the Beatles, Brad Paisley or Bruno Mars. Your favorite music likely triggers a similar type of activity in your brain as other people's favorites do in theirs.

Pfizer initiates rolling submission of crizotinib NDA for ALK-positive advanced NSCLC

Pfizer Inc. announced today that it has initiated the rolling submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for crizotinib (PF-02341066), an oral first-in-class anaplastic lymphoma kinase (ALK) inhibitor for the treatment of patients with advanced non-small cell lung cancer (NSCLC) whose tumors are ALK-positive. Pfizer expects to complete the submission in the first half of 2011.

Read more Medical News

› Verified 8 days ago

• 1
• 2(current)